Cancer Treatment Cost Savings — the article + the world, ranked

A fuller editorial guide to cancer treatment cost savings is coming soon. For now, the ranking below compares every country we have assessed on it — open a country's report for the cited detail behind its score.

The country comparison

Which countries are best for cancer treatment cost savings

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

1 India IN 5.0/5 Good India demonstrates exceptional cancer treatment cost savings of 65-90% compared to Western countries, with comprehensive treatment packages available at $3,000-$30,000. Multiple financing options exist including gover... Full report
The evidence behind this score 5 cited points
- 65-90% cost savings documented across cancer treatments vs US and UK
- Comprehensive treatment packages available at $3,000-$30,000 for complete care
- Multiple financing options: cash, cards, wire transfers, international insurance, government programs
- Immunotherapy: 70-80% savings; CAR-T therapy: up to 90% savings compared to origin countries
- Government initiatives including tax incentives, 200 cancer daycare centers, and streamlined medical visa processes
Read the full India report →
2 Turkey TR 5.0/5 Good Turkey demonstrates exceptional cancer treatment cost savings of 50-80%, with immunotherapy reaching 80% savings compared to the US, comprehensive treatment packages available for $7,000-$20,000 (well under the $25,00... Full report
The evidence behind this score 4 cited points
- Cancer treatment costs 50-70% less than in the U.S. or Western Europe, with immunotherapy reaching up to 80% savings ($8,000-$12,000 in Turkey vs. $50,000-$70,000 in the US)
- Comprehensive treatment packages available for major cancer types: breast cancer at €10,000, colorectal cancer at $5,182-$20,755, ovarian cancer at €10,000-€25,000
- Multiple financing options including international insurance acceptance, installment payment plans from Turkish banks at reduced interest rates, and government support covering up to $1,000 per patient plus 50% of airline costs
- 41 JCI-accredited clinics with transparent pricing and dedicated international patient services in multiple languages
Read the full Turkey report →
3 Malaysia MY 4.5/5 Good Malaysia delivers 60-80% cost savings on major cancer treatments (surgery, chemotherapy, radiation), exceeding Score 4's 50-69% threshold and approaching Score 5's 70%+ target. Most comprehensive cancer packages are p... Full report
The evidence behind this score 8 cited points
- Cancer surgery cost savings: 60-70% (USD 2,000-11,000 vs USD 15,000-50,000+ in US)
- Chemotherapy savings: 75-80% per cycle (USD 500-2,200 vs USD 5,000-11,000 in US)
- Radiotherapy savings: 65-75% (USD 1,000-6,500 vs USD 10,000-30,000 in US)
- Comprehensive treatment packages: breast cancer USD 7,500-28,000, prostate USD 12,000-35,000, lung from USD 16,000
- World-class infrastructure: Sunway Medical Centre ESMO-designated, SJMC first ACHS Centre of Excellence for Oncology in Asia-Pacific
- Advanced treatments: CAR-T USD 75,000-125,000 (40%+ savings vs Singapore), bone marrow transplant USD 27,000-33,000 (40%+ savings vs US)
- Financing barrier: 100% upfront deposit required for surgical admissions, limited formal medical financing for international patients
- Immunotherapy limitation: checkpoint inhibitors USD 66,000-133,000 with no government subsidies, not achieving 50%+ savings vs Western pricing
Read the full Malaysia report →
4 South Korea KR 4.5/5 Good South Korea demonstrates exceptional cancer treatment cost savings of 40-70% compared to the US, UK, and Germany, with many major treatments showing 67-85% savings (e.g., robotic surgery at one-third USA cost, radiati... Full report
The evidence behind this score 5 cited points
- Medical tourists save 40-70% on treatments in Korea compared to the US, UK, or Germany
- Monoclonal antibody therapy costing $150,000 in USA available for $30,000 in South Korea
- Cancer treatment costs range from $7,000 to $30,000 for comprehensive care including treatment, accommodation, and transportation
- Hospitals offer transparent pricing through Korean National Health Insurance Service (NHIS) data structures
- Government actively supports medical tourism through the Act on Support for Overseas Expansion of Healthcare System, visa simplification, and regulation against overcharging
Read the full South Korea report →
5 Hungary HU 4.0/5 Good Hungary offers documented 40–70% cost savings on major cancer treatments compared to high-cost origin countries, with comprehensive multimodal treatment packages (surgery, IMRT, chemotherapy) available for $12,000–$25... Full report
The evidence behind this score 6 cited points
- Cost savings 40–70% vs. UK/US/Nordic countries; specific examples show 80–90% (US $65,000–$150,000 vs. Hungary $12,000–$25,000 for multimodal treatment)
- Complete multimodal cancer treatment packages (surgery + IMRT + chemotherapy) available for $12,000–$25,000 in Budapest
- FirstMed Budapest accepts direct billing from 110+ international insurance partners including Bupa Global, Cigna, Aetna International; Medicover and Duna Medical accept major international plans
- EU Cross-Border Healthcare Directive enables reimbursement up to home country tariff for EU/EEA patients; S2 form route provides direct billing
- Pricing opacity is a significant structural problem; almost no oncology-specific pricing publicly available, forcing patients to request individual quotes
- Advanced immunotherapy severely constrained: pembrolizumab covers only 38.5% of approved indications vs. EU average 59%; out-of-pocket cost ~€4,900/infusion with significant access gaps
Read the full Hungary report →
6 Israel IL 4.0/5 Good Israel achieves 50-75% cost savings on major cancer treatments (chemotherapy, surgery, immunotherapy) compared to the U.S., UK, Canada, and Australia, meeting the 50-69% threshold for Score 4. Treatment packages for c... Full report
The evidence behind this score 6 cited points
- Major cancer surgery savings: 50-70% (Israel $23,000-$31,000 vs. U.S. $50,000-$100,000)
- Chemotherapy: 50-75% savings ($2,000-$7,000 in Israel vs. $10,000-$20,000 in U.S.)
- CAR-T therapy: ~75% savings ($90,000-$120,000 in Israel vs. $400,000-$700,000 in U.S.)
- Common cancer packages: Breast $13,375-$18,000; lung $28,880; prostate $10,000-$60,000
- Immunotherapy savings: up to 85% cheaper than U.S./UK
- 20+ JCI-accredited hospitals with dedicated international patient departments and insurance coordination capability
Read the full Israel report →
7 Jordan JO 4.0/5 Good Jordan demonstrates 50-69% cost savings on major cancer treatments, particularly surgical oncology and radiation therapy, with comprehensive breast cancer packages available at $8,404-13,518 versus $28,000-68,000+ in ... Full report
The evidence behind this score 5 cited points
- Mastectomy costs $24,000 in Jordan versus $40,000-70,000 in the US (40-65% savings); colorectal resection $31,000 versus $50,000-80,000 in the US
- Breast cancer first-year treatment documented at $8,404-13,518 across stages versus $28,000-68,000+ in the US (50-80% savings)
- Radiation therapy IMRT courses $16,000 versus $30,000-35,000+ in the US; bone marrow transplantation $25,000-40,000 versus $1,071,700 in the US
- Advanced therapies (pembrolizumab $144,709/year, osimertinib 3-year course $259,431) show minimal discount from US rates due to global pharmaceutical pricing
- KHCC Cancer Care Insurance open to all nationalities; major hospitals accept Cigna Global, Allianz Care, and AXA PPP direct billing
Read the full Jordan report →
8 United Arab Emirates AE 4.0/5 Good The United Arab Emirates delivers 50-75% cost savings on major cancer treatments compared to the United States and 30-65% versus the United Kingdom, with breast cancer packages at USD 9,080-35,000 documented at accred... Full report
The evidence behind this score 6 cited points
- UAE cancer treatment costs USD 8,000-35,000 for breast cancer care versus US equivalent of USD 50,000-150,000+, representing 50-75% savings; vs. UK USD 20,000-100,000, representing 30-65% savings
- Comprehensive breast cancer treatment packages at Burjeel Hospital Abu Dhabi priced USD 9,080-16,618; radiation therapy USD 10,000-36,790; chemotherapy per cycle USD 1,090-4,080
- Direct billing arrangements established with major international insurers (Cigna International, BUPA International, Aetna International, AXA, Allianz); 12-month instalment plans available
- Pricing transparency gap documented: UAE hospitals require direct inquiry for personalized cost estimates, unlike India or Turkey where comprehensive package pricing is publicly accessible on hospital websites
- Government subsidy programs (Basmah in Dubai, Abu Dhabi presidential mandate) explicitly reserved for UAE residents and Emiratis; non-resident international tourists do not qualify
- Currency advantage limited: UAE dirham pegged to USD (no advantage for US patients); moderate fluctuation benefits only for British, Australian, Canadian, European patients
Read the full United Arab Emirates report →
9 Colombia CO 4.0/5 Good Colombia delivers 50–70% cost savings on major cancer treatments, with comprehensive packages available at $10,000–$30,000 versus U.S. costs of $80,000–$200,000+. Multiple international insurers (Cigna Global, Bupa, A... Full report
The evidence behind this score 7 cited points
- Comprehensive cancer packages (surgery + chemotherapy + radiation + follow-up) cost $10,000–$30,000 in Colombia versus $80,000–$200,000+ in the US (50–90% savings for surgical cases)
- Major surgery savings: mastectomy with reconstruction $2,500–$5,000 in Colombia versus $15,000–$55,000 in the US (60–90% savings)
- Radiation therapy full courses $6,000–$10,000 in Colombia versus $17,000–$25,000 in the US (40–60% savings)
- Six JCI-accredited hospitals accept direct billing from major international insurers (Cigna Global, Bupa, AXA, Allianz) and international patient departments with English-speaking coordinators
- No formal government subsidies or tax incentives for international cancer patients, unlike competing destinations (Thailand, Turkey)
- Fee-for-service billing structure complicates transparent total-cost estimation; hidden costs can add 20–40% to quoted prices
- Immunotherapy (pembrolizumab, nivolumab) remains expensive at $50,000–$120,000 per year self-pay; drug-intensive regimens generate only 30–50% savings, limiting advanced-therapy cost advantage
Read the full Colombia report →
10 Germany DE 4.0/5 Good Germany demonstrates 45-80% cost savings on major cancer treatments versus the USA, with treatment packages for common cancers ranging €14,000-€85,000, and transparent G-DRG pricing that applies equally to all patient... Full report
The evidence behind this score 6 cited points
- Major cancer surgery 45-65% cheaper than USA (€25,000-€45,000 vs €65,000-€85,000)
- Chemotherapy up to 80% savings over USA ($1,200-$5,000 vs $13,000 average)
- Treatment packages: prostate €14,000-€38,000; colorectal €18,000-€48,000; breast €45,000-€85,000
- G-DRG regulated pricing with legally mandated transparent cost estimates; no foreigner markup
- International insurance accepted (Cigna, Allianz); facilitator insurance up to €200,000 for complications
- Advanced treatments: HIPEC 40-50% cheaper than USA; Lu-177 PSMA €12,700-€28,900; proton therapy €15,000-€35,000
Read the full Germany report →
11 Spain ES 4.0/5 Good Spain achieves 40–70% cost savings on major cancer treatments compared to high-cost origin countries (US, UK, Canada, Australia), meeting the Score 4 threshold of 50–69%. Comprehensive treatment packages for common ca... Full report
The evidence behind this score 5 cited points
- ISPOR Europe 2024 study documents median 62% discount on branded oncology drugs in Spain vs. US (oral targeted agents 73%, biologics 59%)
- Advanced breast cancer treatment: 60–80% savings ($25,000–$60,000 in Spain vs. $150,000–$200,000 in US)
- Hospital Ruber Internacional comprehensive oncology package: $13,170 including consultations, medications, and follow-up blood work
- Early-stage cancer packages widely available under $40,000 (breast cancer $5,000–$15,000, early colorectal from $18,000)
- International health insurance (Allianz, AXA, Cigna Global, Bupa) operates in Spain with direct billing at major private hospitals; however, pricing is not transparently published and requires direct inquiry
Read the full Spain report →
12 Mexico MX 4.0/5 Good Mexico demonstrates strong cost competitiveness with 50-70% savings on major cancer treatments compared to high-cost origin countries, comprehensive treatment packages under $40,000, transparent pricing, and flexible ... Full report
The evidence behind this score 7 cited points
- 50-70% cost savings on major cancer treatments compared to US, UK, Canada, Australia
- Comprehensive cancer treatment packages available at $5,000-$30,000 for complete care
- Chemotherapy at 71% savings ($1,500-$4,000 per session vs $13,000 in US)
- Transparent upfront pricing with all-inclusive packages covering consultations, diagnostics, treatment, accommodation, and meals
- Installment payment plans available, though most U.S. insurance does not cover international treatment
- Favorable currency exchange rate providing additional savings for international patients
- Advanced facilities with JCI accreditation providing quality care at reduced costs
Read the full Mexico report →
13 Thailand TH 4.0/5 Good Thailand demonstrates strong cost savings of 50-70% on major cancer treatments compared to high-cost origin countries (US, UK, Australia), with extensive financing options and insurance acceptance at 60+ JCI-accredite... Full report
The evidence behind this score 5 cited points
- 60-70% cost savings on cancer treatments compared to US/UK/Australia; patients save 50-70% average
- Chemotherapy costs $2,000-$5,000 (73% savings vs $13,000 US); radiation $5,500-$10,000 (74% savings vs $30,000 US)
- Multiple financing options with insurance acceptance at leading hospitals; government CIT incentives for cancer centers
- 60+ Joint Commission International-accredited hospitals; Bumrungrad's advanced oncology center treating 18,000+ patients annually
- Immunotherapy available at $20,000-$40,000 (33% less than US costs); comprehensive treatment packages 2-3× lower than separate procedure costs
Read the full Thailand report →
14 Poland PL 3.5/5 Moderate Poland demonstrates 50-70% cost savings on major surgical oncology procedures (mastectomy at USD 2,905 vs USD 30,000-50,000 in the US), meeting the lower threshold for Score 4. Some financing options and insurance acc... Full report
The evidence behind this score 5 cited points
- 50-70% cost savings on major surgical oncology procedures compared to Western Europe and US, with mastectomy documented at USD 2,905 versus USD 30,000-50,000 in the US
- Comprehensive surgical-focused packages available in USD 2,900-77,900 range depending on procedure complexity and treatment modalities
- Pricing transparency issues identified: majority of Polish oncology centres display 'price upon request' rather than published rates, complicating pre-trip budgeting
- Pharmaceutical pricing paradox: Poland recorded among the highest per-unit prices for key oncology medicines relative to national income, with drug costs that 'could partially cancel out procedural savings' for immunotherapy and targeted therapy patients
- Limited financing for international patients: LM PAY installment plans available but 'primarily target Polish residents'; international patients typically pay via wire transfer or credit card
Read the full Poland report →
15 Brazil BR 3.5/5 Moderate Brazil offers strong value for surgical oncology and standard chemotherapy patients from high-income countries (40–60% savings vs. US, packages under $40,000), with broad insurance acceptance and favorable currency ex... Full report
The evidence behind this score 6 cited points
- 40–60% cost savings on surgical oncology and standard chemotherapy documented vs. US; specific examples include mastectomy with reconstruction at $15,000–$35,000 vs. $60,000–$120,000 in US, and FOLFOX chemotherapy at $2,000–$12,000 vs. $30,000–$60,000 in US
- BRL depreciation of 21.5% in 2024 (5.39 to 6.18 BRL/USD) provides significant additional currency advantage for USD-holding patients
- Pembrolizumab and nivolumab are 225% and 362% more expensive respectively than in Canada and New Zealand, eliminating cost advantage for immunotherapy-dependent advanced cancer patients
- Pricing transparency is limited; hospitals operate on quote-upon-inquiry model with no public price lists, and cost estimates vary by surgeon grade and room category
- Top hospitals accept 60+ international insurance plans with direct-billing arrangements, partially offsetting lack of government subsidies and formal financing for international patients
- No proton therapy available in Brazil or anywhere in Latin America; stereotactic body radiotherapy available in only 16% of Brazilian radiation departments, limiting access to advanced modalities
Read the full Brazil report →
16 Singapore SG 3.0/5 Moderate Singapore offers moderate cost savings of 25–40% on most major cancer treatments versus high-cost countries like the US, with particular strength in radiation therapy (50–65% savings) and surgical oncology. However, c... Full report
The evidence behind this score 5 cited points
- Overall cost savings of 25–40% versus high-cost countries (US, UK, Canada, Australia), with radiation therapy offering 50–65% specific savings
- 18-month comprehensive cancer treatment costs ranging $70,000–$200,000 (lung cancer $199,500, breast cancer $134,500) exceed $50,000 threshold
- Immunotherapy costs $113,000–$170,000 annually, comparable to Western markets with 0% savings; CAR-T therapy ~$475,000, also comparable globally
- Strong international insurance acceptance (BUPA, Cigna, Aetna, Allianz, AXA) with direct-billing arrangements, but no government subsidies or incentive programs for international patients
- Transparent pricing through bill estimators and dedicated international coordinators, but pricing is primarily fee-for-service rather than all-inclusive packages
Read the full Singapore report →
17 Japan JP 2.5/5 Moderate Japan offers exceptional particle radiotherapy savings (70-80% vs US) but this represents a specialized niche within oncology. For the broader cancer treatment landscape, Japan lacks comprehensive packages, financing ... Full report
The evidence behind this score 5 cited points
- Particle therapy savings of 70-80% ($27,000-$33,000 for carbon-ion vs US $100,000-$150,000) represents world-leading value for this modality only
- Japan's anticancer drug prices are the highest in East Asia ($50,859 median), with 3× international patient multiplier approaching or matching US self-pay costs
- Explicit red flags: no comprehensive treatment packages, no financing options, no government subsidies, cash-only prepayment requirement with no discounts
- Integrated treatment scenario (surgery + chemotherapy + particle therapy + accommodation) totals $124,000-$191,000—not dramatically cheaper than US integrated care
- Report concludes patients seeking standard oncology care would find significantly lower costs in India, Thailand, or South Korea
Read the full Japan report →
18 United Kingdom GB 1.0/5 Poor The United Kingdom is among the world's most expensive destinations for cancer treatment, not a cost-savings destination. UK private cancer costs are 3-5× higher than India, 70-85% more expensive than Turkey and Thail... Full report
The evidence behind this score 6 cited points
- UK breast cancer treatment costs USD $20,000–$100,000 vs Thailand's $7,500–$23,000 (2.7-13× more expensive)
- UK mastectomy £9,000–£18,000 vs India's equivalent $4,500–$6,000 (3-5× higher cost)
- UK immunotherapy for lung cancer $60,000–$100,000 vs Turkey $2,200–$5,400 representing up to 85% cost disadvantage for UK
- Pricing transparency is a significant barrier with most major UK private cancer centres not publishing costs online; requires individual inquiry
- No government subsidies, medical tourism incentives, or state-funded pathways for international cancer patients
- No meaningful consumer financing products available; advance payment required for self-pay international patients
Read the full United Kingdom report →
19 United States US 1.0/5 Poor The United States is the world's highest-cost environment for cancer treatment, with costs 50-80% higher than international medical tourism alternatives. There are no comprehensive treatment packages available for int... Full report
The evidence behind this score 5 cited points
- Cancer treatment costs in the US are 50-80% higher than medical tourism destinations like India, Mexico, Thailand, and Turkey
- Immunotherapy costs exceed $100,000 per patient, with some therapies reaching $850,000 including medical support
- Monthly chemotherapy costs range from $1,000-$12,000; Americans travel abroad because treatment costs $4,000 in Mexico versus $12,000 in the US
- No comprehensive cancer treatment packages exist for international patients; US facilities offer complex fee-for-service pricing only
- Extreme pricing opacity and variation: identical chemotherapy drug costs $134 at one clinic and $13,560 at another, with hospitals marking up drugs 2.5-3 times acquisition cost, reaching 350 times higher in extreme cases
Read the full United States report →

See the full ranking, the 1–5 rubric and the reports →